Qiagen N.V. (QGEN)
USD 42.32
(0.81%)
USD 42.32
(0.81%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 341.3 Million USD | -19.35% |
| 2022 | 423.21 Million USD | -17.44% |
| 2021 | 512.59 Million USD | 596.09% |
| 2020 | 73.64 Million USD | 277.64% |
| 2019 | -41.45 Million USD | -121.77% |
| 2018 | 190.38 Million USD | 371.31% |
| 2017 | 40.39 Million USD | -49.76% |
| 2016 | 80.4 Million USD | -36.74% |
| 2015 | 127.1 Million USD | 8.98% |
| 2014 | 116.63 Million USD | 68.86% |
| 2013 | 69.07 Million USD | -46.66% |
| 2012 | 129.5 Million USD | 34.85% |
| 2011 | 96.03 Million USD | -33.45% |
| 2010 | 144.31 Million USD | 4.75% |
| 2009 | 137.76 Million USD | 54.74% |
| 2008 | 89.03 Million USD | 77.63% |
| 2007 | 50.12 Million USD | -28.94% |
| 2006 | 70.53 Million USD | 13.36% |
| 2005 | 62.22 Million USD | 27.76% |
| 2004 | 48.7 Million USD | 13.66% |
| 2003 | 42.85 Million USD | 85.16% |
| 2002 | 23.14 Million USD | -32.76% |
| 2001 | 34.41 Million USD | 71.19% |
| 2000 | 20.1 Million USD | 59.36% |
| 1999 | 12.61 Million USD | 1.75% |
| 1998 | 12.4 Million USD | 40.91% |
| 1997 | 8.8 Million USD | 66.04% |
| 1996 | 5.3 Million USD | 120.83% |
| 1995 | 2.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 80.67 Million USD | -17.4% |
| 2024 Q2 | -183.46 Million USD | -327.41% |
| 2023 Q1 | 85.03 Million USD | -4.29% |
| 2023 Q3 | 77.81 Million USD | -3.67% |
| 2023 Q4 | 97.66 Million USD | 25.5% |
| 2023 FY | 341.3 Million USD | -19.35% |
| 2023 Q2 | 80.78 Million USD | -5.0% |
| 2022 Q1 | 155.31 Million USD | 20.22% |
| 2022 Q4 | 88.84 Million USD | 7.83% |
| 2022 FY | 423.21 Million USD | -17.44% |
| 2022 Q2 | 96.66 Million USD | -37.76% |
| 2022 Q3 | 82.39 Million USD | -14.76% |
| 2021 Q2 | 121.05 Million USD | -6.32% |
| 2021 Q4 | 129.18 Million USD | -2.97% |
| 2021 FY | 512.59 Million USD | 596.09% |
| 2021 Q1 | 129.22 Million USD | -39.24% |
| 2021 Q3 | 133.13 Million USD | 9.99% |
| 2020 Q2 | 89.76 Million USD | 125.37% |
| 2020 FY | 73.64 Million USD | 277.64% |
| 2020 Q1 | 39.82 Million USD | -11.36% |
| 2020 Q3 | 16.91 Million USD | -81.16% |
| 2020 Q4 | 212.68 Million USD | 1157.75% |
| 2019 FY | -41.45 Million USD | -121.77% |
| 2019 Q1 | 29.52 Million USD | -51.57% |
| 2019 Q2 | 44.72 Million USD | 51.52% |
| 2019 Q3 | -160.63 Million USD | -459.14% |
| 2019 Q4 | 44.93 Million USD | 127.97% |
| 2018 Q4 | 60.95 Million USD | 1.04% |
| 2018 Q3 | 60.32 Million USD | 63.85% |
| 2018 Q2 | 36.81 Million USD | 14.0% |
| 2018 Q1 | 32.29 Million USD | 181.36% |
| 2018 FY | 190.38 Million USD | 371.31% |
| 2017 Q1 | 17.65 Million USD | 64.07% |
| 2017 Q4 | -39.69 Million USD | -181.87% |
| 2017 FY | 40.39 Million USD | -49.76% |
| 2017 Q3 | 48.48 Million USD | 247.54% |
| 2017 Q2 | 13.95 Million USD | -20.96% |
| 2016 Q4 | 10.75 Million USD | -69.09% |
| 2016 Q1 | 15.71 Million USD | -67.65% |
| 2016 Q2 | 21.26 Million USD | 35.36% |
| 2016 Q3 | 34.8 Million USD | 63.66% |
| 2016 FY | 80.4 Million USD | -36.74% |
| 2015 Q1 | 19.49 Million USD | -24.58% |
| 2015 FY | 127.1 Million USD | 8.98% |
| 2015 Q3 | 33.93 Million USD | 35.13% |
| 2015 Q2 | 25.11 Million USD | 28.84% |
| 2015 Q4 | 48.57 Million USD | 43.16% |
| 2014 Q1 | 23.26 Million USD | -61.32% |
| 2014 Q4 | 25.84 Million USD | -25.5% |
| 2014 FY | 116.63 Million USD | 68.86% |
| 2014 Q2 | 32.83 Million USD | 41.12% |
| 2014 Q3 | 34.68 Million USD | 5.65% |
| 2013 Q1 | 19.98 Million USD | -47.99% |
| 2013 FY | 69.07 Million USD | -46.66% |
| 2013 Q4 | 60.15 Million USD | 47.79% |
| 2013 Q3 | 40.7 Million USD | 178.63% |
| 2013 Q2 | -51.76 Million USD | -359.03% |
| 2012 FY | 129.5 Million USD | 34.85% |
| 2012 Q3 | 29.16 Million USD | -12.51% |
| 2012 Q2 | 33.33 Million USD | 16.58% |
| 2012 Q1 | 28.59 Million USD | 7704.26% |
| 2012 Q4 | 38.41 Million USD | 31.74% |
| 2011 Q4 | -376 Thousand USD | -101.07% |
| 2011 Q1 | 27.98 Million USD | -22.89% |
| 2011 Q2 | 33.28 Million USD | 18.97% |
| 2011 FY | 96.03 Million USD | -33.45% |
| 2011 Q3 | 35.14 Million USD | 5.58% |
| 2010 Q1 | 33.01 Million USD | -25.75% |
| 2010 Q2 | 38.52 Million USD | 16.68% |
| 2010 Q3 | 36.48 Million USD | -5.28% |
| 2010 FY | 144.31 Million USD | 4.75% |
| 2010 Q4 | 36.28 Million USD | -0.55% |
| 2009 Q2 | 30.92 Million USD | 25.3% |
| 2009 Q3 | 37.69 Million USD | 21.86% |
| 2009 FY | 137.76 Million USD | 54.74% |
| 2009 Q4 | 44.46 Million USD | 17.97% |
| 2009 Q1 | 24.68 Million USD | 0.0% |
| 2008 Q4 | 24.68 Million USD | 18.72% |
| 2008 FY | 89.03 Million USD | 77.63% |
| 2008 Q1 | 20.33 Million USD | 35.55% |
| 2008 Q3 | 20.79 Million USD | -10.48% |
| 2008 Q2 | 23.22 Million USD | 14.22% |
| 2007 FY | 50.12 Million USD | -28.94% |
| 2007 Q4 | 15 Million USD | 304.69% |
| 2007 Q2 | 22.58 Million USD | 13.67% |
| 2007 Q1 | 19.86 Million USD | 2.16% |
| 2007 Q3 | -7.32 Million USD | -132.45% |
| 2006 Q4 | 19.44 Million USD | 0.46% |
| 2006 Q2 | 14.15 Million USD | -19.49% |
| 2006 Q1 | 17.58 Million USD | 4.27% |
| 2006 Q3 | 19.35 Million USD | 36.77% |
| 2006 FY | 70.53 Million USD | 13.36% |
| 2005 Q4 | 16.86 Million USD | -4.42% |
| 2005 FY | 62.22 Million USD | 27.76% |
| 2005 Q1 | 13.94 Million USD | -11.96% |
| 2005 Q2 | 13.77 Million USD | -1.23% |
| 2005 Q3 | 17.64 Million USD | 28.04% |
| 2004 Q4 | 15.84 Million USD | 25.33% |
| 2004 Q3 | 12.64 Million USD | 43.6% |
| 2004 Q2 | 8.8 Million USD | -22.93% |
| 2004 Q1 | 11.42 Million USD | 27.08% |
| 2004 FY | 48.7 Million USD | 13.66% |
| 2003 FY | 42.85 Million USD | 85.16% |
| 2003 Q2 | 11.1 Million USD | 0.98% |
| 2003 Q1 | 10.99 Million USD | 520.14% |
| 2003 Q4 | 8.98 Million USD | -23.61% |
| 2003 Q3 | 11.76 Million USD | 5.96% |
| 2002 FY | 23.14 Million USD | -32.76% |
| 2002 Q1 | 9.5 Million USD | -13.06% |
| 2002 Q2 | 4.57 Million USD | -51.88% |
| 2002 Q3 | 7.28 Million USD | 59.36% |
| 2002 Q4 | 1.77 Million USD | -75.68% |
| 2001 Q3 | 6.19 Million USD | -45.36% |
| 2001 FY | 34.41 Million USD | 71.19% |
| 2001 Q4 | 10.93 Million USD | 76.55% |
| 2001 Q1 | 5.95 Million USD | -9.52% |
| 2001 Q2 | 11.33 Million USD | 90.28% |
| 2000 Q3 | 6.49 Million USD | 355.29% |
| 2000 FY | 20.1 Million USD | 59.36% |
| 2000 Q4 | 6.58 Million USD | 1.34% |
| 2000 Q2 | 1.42 Million USD | -74.87% |
| 2000 Q1 | 5.67 Million USD | 1486.31% |
| 1999 FY | 12.61 Million USD | 1.75% |
| 1999 Q1 | 3.8 Million USD | 2.7% |
| 1999 Q2 | 4.21 Million USD | 10.92% |
| 1999 Q3 | 4.75 Million USD | 12.81% |
| 1999 Q4 | 358 Thousand USD | -92.47% |
| 1998 Q3 | 3.2 Million USD | 10.34% |
| 1998 Q2 | 2.9 Million USD | 11.54% |
| 1998 Q1 | 2.6 Million USD | -10.34% |
| 1998 FY | 12.4 Million USD | 40.91% |
| 1998 Q4 | 3.7 Million USD | 15.63% |
| 1997 Q2 | 1.9 Million USD | -5.0% |
| 1997 Q1 | 2 Million USD | 11.11% |
| 1997 Q4 | 2.9 Million USD | 45.0% |
| 1997 Q3 | 2 Million USD | 5.26% |
| 1997 FY | 8.8 Million USD | 66.04% |
| 1996 Q4 | 1.8 Million USD | 20.0% |
| 1996 Q1 | 1 Million USD | 0.0% |
| 1996 FY | 5.3 Million USD | 120.83% |
| 1996 Q3 | 1.5 Million USD | 36.36% |
| 1996 Q2 | 1.1 Million USD | 10.0% |
| 1995 FY | 2.4 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.24 Billion USD | 72.476% |
| Charles River Laboratories International, Inc. | 474.62 Million USD | 28.09% |
| Quest Diagnostics Incorporated | 854 Million USD | 60.035% |
| Danaher Corporation | 4.76 Billion USD | 92.836% |
| Enzo Biochem, Inc. | -26.07 Million USD | 1408.778% |
| IQVIA Holdings Inc. | 1.35 Billion USD | 74.867% |
| Laboratory Corporation of America Holdings | 418 Million USD | 18.349% |
| Mettler-Toledo International Inc. | 788.77 Million USD | 56.73% |
| Revvity, Inc. | 693.09 Million USD | 50.757% |
| Thermo Fisher Scientific Inc. | 5.99 Billion USD | 94.307% |
| Waters Corporation | 642.23 Million USD | 46.857% |